370 related articles for article (PubMed ID: 18708107)
1. Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model.
Xu XG; Liu HJ
Vaccine; 2008 Oct; 26(43):5455-60. PubMed ID: 18708107
[TBL] [Abstract][Full Text] [Related]
2. Baculovirus surface display of E(rns) envelope glycoprotein of classical swine fever virus.
Xu XG; Chiou MT; Zhang YM; Tong DW; Hu JH; Zhang MT; Liu HJ
J Virol Methods; 2008 Nov; 153(2):149-55. PubMed ID: 18727937
[TBL] [Abstract][Full Text] [Related]
3. Baculovirus surface display of sigmaC and sigmaB proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model.
Lin YH; Lee LH; Shih WL; Hu YC; Liu HJ
Vaccine; 2008 Nov; 26(50):6361-7. PubMed ID: 18809448
[TBL] [Abstract][Full Text] [Related]
4. Baculovirus surface display of NS3 nonstructural protein of classical swine fever virus.
Xu XG; Tong DW; Chiou MT; Hsieh YC; Shih WL; Chang CD; Liao MH; Zhang YM; Liu HJ
J Virol Methods; 2009 Aug; 159(2):259-64. PubMed ID: 19406162
[TBL] [Abstract][Full Text] [Related]
5. Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2.
Xu XG; Wang ZS; Zhang Q; Li ZC; Ding L; Li W; Wu HY; Chang CD; Lee LH; Tong DW; Liu HJ
J Virol Methods; 2012 Feb; 179(2):359-66. PubMed ID: 22172969
[TBL] [Abstract][Full Text] [Related]
6. Immune responses induced by a BacMam virus expressing the E2 protein of classical swine fever virus in mice.
Li M; Wang YF; Wang Y; Gao H; Li N; Sun Y; Liang BB; Qiu HJ
Immunol Lett; 2009 Aug; 125(2):145-50. PubMed ID: 19589357
[TBL] [Abstract][Full Text] [Related]
7. Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models.
Xu XG; Wang ZS; Zhang Q; Li ZC; Zhao HN; Li W; Tong DW; Liu HJ
Vaccine; 2011 Jan; 29(4):636-43. PubMed ID: 21115062
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model.
Zhao HP; Sun JF; Li N; Sun Y; Xia ZH; Wang Y; Cheng D; Qi QF; Jin ML; Qiu HJ
Vet Immunol Immunopathol; 2009 May; 129(1-2):57-65. PubMed ID: 19150136
[TBL] [Abstract][Full Text] [Related]
9. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
[TBL] [Abstract][Full Text] [Related]
10. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge.
Li N; Qiu HJ; Zhao JJ; Li Y; Wang MJ; Lu BW; Han CG; Hou Q; Wang ZH; Gao H; Peng WP; Li GX; Zhu QH; Tong GZ
Vaccine; 2007 Apr; 25(15):2907-12. PubMed ID: 17007970
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
12. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
[TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
[TBL] [Abstract][Full Text] [Related]
15. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the protective efficacy of recombinant adenoviruses against classical swine fever.
Sun Y; Li HY; Zhang XJ; Chang TM; He F; Wang XP; Liu DF; Qiu HJ
Immunol Lett; 2011 Mar; 135(1-2):43-9. PubMed ID: 20923683
[TBL] [Abstract][Full Text] [Related]
17. Generation and efficacy evaluation of a recombinant adenovirus expressing the E2 protein of classical swine fever virus.
Sun Y; Liu DF; Wang YF; Liang BB; Cheng D; Li N; Qi QF; Zhu QH; Qiu HJ
Res Vet Sci; 2010 Feb; 88(1):77-82. PubMed ID: 19586646
[TBL] [Abstract][Full Text] [Related]
18. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
Tarradas J; Monsó M; Muñoz M; Rosell R; Fraile L; Frías MT; Domingo M; Andreu D; Sobrino F; Ganges L
Vaccine; 2011 Jun; 29(26):4422-9. PubMed ID: 21496472
[TBL] [Abstract][Full Text] [Related]
19. [Generation and immunogenicity of a recombinant adenovirus expressing the E2 protein of classical swine fever virus in rabbits].
Sun Y; Qi Q; Liang B; Cheng D; Li N; Yu M; Wang Y; Liu N; Zhu Q; Qiu H
Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1734-9. PubMed ID: 19149185
[TBL] [Abstract][Full Text] [Related]
20. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge.
Sánchez O; Barrera M; Rodríguez MP; Frías MT; Figueroa NE; Naranjo P; Montesino R; Farnos O; Castell S; Venereo A; Ganges L; Borroto C; Toledo JR
Vaccine; 2008 Feb; 26(7):988-97. PubMed ID: 18192093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
